ニュース

PharmaTimes1 日

ANGLE partners with Myriad Genetics to explore blood-based cancer testing

ANGLE has announced a collaboration with Myriad Genetics to assess whether circulating tumour cell (CTC) DNA harvested from blood samples using ANGLE’s Parsortix system can be used alongside Myriad’s ...
PharmaTimes1 日

Friends of Cancer Research and MMS partner to improve interpretation of cancer trial ...

Friends of Cancer Research has announced a new collaboration with global clinical research organisation, MMS, to develop decision frameworks that will help interpret interim overall survival (OS) data ...
PharmaTimes3 日

FDA grants Breakthrough Therapy Designation to lung cancer therapy

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan ...
PharmaTimes4 日

Ogsiveo approved in EU for treatment of desmoid tumors

Merck has announced that the European Commission has granted marketing authorisation for Ogsiveo (nirogacestat) as ...
PharmaTimes3 日

Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of ...

Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable Platform Funding Call to support the ...
PharmaTimes4 日

Upperton and Oxford join forces to develop oral vaccine formulation

Upperton Pharma Solutions has secured funding from the first VaxHub Sustainable Platform Funding Call to support the ...